JD Health International Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	25,177	22,629	15,037	18,718	17,252	32,271
Short-Term Investments	19,757	18,169	16,799	27,951	23,637	6,525
Trading Asset Securities	4,371	10,438	9,385	1,003	1,101	1,508
Cash & Short-Term Investments	49,306	51,236	41,221	47,672	41,990	40,303
Cash Growth	2.89%	24.29%	-13.53%	13.53%	4.18%	533.65%
Accounts Receivable	705.82	857.92	706.76	1,301	405.68	460.86
Other Receivables	287.64	289.04	265.35	686.59	53.75	46.39
Receivables	993.46	1,147	972.1	1,988	459.43	507.25
Inventory	7,455	5,843	5,085	5,996	3,041	1,732
Prepaid Expenses	33.59	20.72	16.35	15.79	14.03	6.67
Restricted Cash	116.81	32.66	15.38	33	25.35	38.6
Other Current Assets	323.22	181.73	540.23	742.43	175.35	116.45
Total Current Assets	58,228	58,460	47,850	56,447	45,705	42,705
Property, Plant & Equipment	963.98	795.99	288	251.91	260.78	115.01
Long-Term Investments	16,869	9,584	13,197	1,523	1,031	714.14
Other Intangible Assets	2,027	2,095	2,182	2,268	25.39	28.5
Long-Term Deferred Tax Assets	348.71	312.93	299.83	208.47	95.86	21.69
Other Long-Term Assets	23.37	26.89	471.77	578.98	883.8	410.44
Total Assets	78,460	71,275	64,288	61,277	48,002	43,995
Accounts Payable	16,603	12,484	11,340	11,143	5,710	2,900
Accrued Expenses	419.92	391.88	305.78	1,204	180.82	171.57
Current Portion of Leases	154.14	109.67	95.32	70.65	67.55	28.57
Current Income Taxes Payable	324.4	207.1	337.54	380.19	118.81	132.18
Current Unearned Revenue	464.12	537.92	405.6	1,375	395.41	179.46
Other Current Liabilities	1,944	1,791	2,100	2,184	1,532	1,270
Total Current Liabilities	19,910	15,521	14,585	16,356	8,005	4,682
Long-Term Leases	275.55	148.72	119.43	128.76	133.72	61.41
Long-Term Deferred Tax Liabilities	297.74	364.41	213.61	7.82	8.89	-
Total Liabilities	20,483	16,034	14,918	16,493	8,148	4,743
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	60,887	59,977	58,551	57,063	56,242	55,633
Retained Earnings	-10,628	-13,224	-17,336	-19,382	-19,715	-18,603
Treasury Stock	-47.52	-60.73	-92.57	-34.3	-50.64	-
Comprehensive Income & Other	7,761	8,539	8,233	7,134	3,377	2,221
Total Common Equity	57,972	55,231	49,356	44,780	39,853	39,251
Minority Interest	4.58	9.68	14.51	4.31	1.19	0.5
Shareholders' Equity	57,977	55,241	49,370	44,785	39,855	39,251
Total Liabilities & Equity	78,460	71,275	64,288	61,277	48,002	43,995
Total Debt	429.69	258.39	214.75	199.41	201.27	89.98
Net Cash (Debt)	48,876	50,977	41,007	47,473	41,789	40,213
Net Cash Growth	2.46%	24.32%	-13.62%	13.60%	3.92%	-
Net Cash Per Share	15.38	16.13	12.96	15.10	13.50	18.21
Filing Date Shares Outstanding	3,160	3,146	3,127	3,106	3,098	3,184
Total Common Shares Outstanding	3,160	3,146	3,127	3,106	3,098	3,184
Working Capital	38,318	42,939	33,265	40,091	37,700	38,023
Book Value Per Share	18.34	17.56	15.78	14.42	12.86	12.33
Tangible Book Value	55,945	53,137	47,174	42,512	39,828	39,222
Tangible Book Value Per Share	17.70	16.89	15.08	13.69	12.86	12.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.